Lowly Expressed Ribosomal Protein S19 in the Feces of Patients with Colorectal Cancer

Table 1

Clinical characteristics of CRC patients.

Variable	No. of cases	Level of fecal RPS19 (%); (≥2.76×10^−5)	P
Age (yr)*			0.448
<64.7	47	27 (57.4)
≥64.7	54	35 (64.8)
Gender			0.140
Male	69	39 (56.5)
Female	32	23 (71.9)
Depth of invasion			0.303
T1 + T2	15	11 (73.3)
T3 + T4	86	51 (59.3)
Lymphatic invasion			0.068
N0	53	37 (69.8)
N1 + N2 + N3	48	25 (52.1)
Distant metastasis			0.183
No	84	54 (64.3)
Yes	17	8 (47.1)
Tumor size (cm)**			0.682
<4.7	61	36 (59.0)
≥4.7	38	24 (63.2)
CEA (ng/mL)**			0.907
≤5	61	37 (60.7)
>5	37	22 (59.5)
CA19-9 (U/mL)**			0.829
<37	74	45 (60.8)
≥37	24	14 (58.3)

*mean age of 101 patients, 64.7 ys (range, 37.3–89.5). **available cases in tumor size, 99; in serum CEA and CA19-9 determinant, 98.